Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Welcome to Natera’s 2024 Third Quarter Financial Results ...

Good morning and welcome to Agenus' third quarter 2024 conference call and webcast. All participants will be in a listen-only ...

About Aptevo Therapeutics Inc. Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies for the treatment of cancer. Aptevo is seeking ...

Merus’ zenocutuzumab is nearing FDA approval, and petosemtamab shows promise. Learn why MRUS stock could rise as the company ...

CET/CEST The issuer is solely responsible for the content of this announcement. CureVac to Present at the 12th Interna ...

CureVac (CVAC) announced that new and updated data will be shared in two oral presentations and four posters at the 12th International mRNA ...

Issuer: CureVac / Key word (s): Conference CureVac to Present at the 12th International mRNA Health Conference 04.11.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this ...

As of September 30, 2024, Zymeworks has repurchased 1,818,530 shares of the Company's common stock for a cost of $20.6 ...

Secretary for Health Prof Lo Chung-mau led a delegation to attend the 2024 Guangdong-Hong Kong-Macao Greater Bay Area Medical Products Administration Conference in Zhuhai today. During the conference, ...

The following abstracts showcase the top cutting-edge research presented at the European Society for Medical Oncology (ESMO) Congress 2024. Topics covered include the use of AI in breast cancer ...

The presentation will expand on safety, tolerability and immunogenicity results of the CVGBM trial presented last month at the European Society for Medical Oncology (ESMO) Congress, which ...

Whether you work on a small or large team, a conference call service can help you conduct virtual audio and video meetings with people located around the world. Conference calling platforms ...